Newsroom

Sorted by: Latest
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Value Line Dividend Index UCITS ETF 14.01.2026 FVD. IE00BKVKW020 250,002.00 USD 7,205,101.41 28.820  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Capital Strength ESG Leaders UCITS ETF 14.01.2026 FCSG IE00BKPSPT20 1,400,002.00 USD 61,134,445.37 43.667  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Opportunities UCITS ETF 14.01.2026 FPX. IE00BYTH6238 225,002.00 USD 14,066,815.08 62.519  ...
-

Massachusetts Financial Services Company UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION   (a) Full name of discloser: Massachusetts Financial Services Company (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficia...
-

Dichiarazione congiunta tra settori: il co-trattamento nell'industria del cemento dovrebbe essere più ampiamente adottato per una gestione dei rifiuti sostenibile a livello globale

LONDRA--(BUSINESS WIRE)--Le maggiori organizzazioni del settore oggi hanno pubblicato una dichiarazione congiunta che evidenzia il contributo sostanziale e positivo che l'industria del cemento può fare per affrontare l'urgente sfida globale dei rifiuti non riciclabili e non riutilizzabili. La Global Cement and Concrete Association – GCCA; la European Composites Industry Association (EuCIA); la International Solid Waste Association – Africa; la Mission Possible Partnership; e il Global Waste-to-...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Emerging Markets AlphaDEX UCITS ETF 14.01.2026 FEM IE00B8X9NX34 325,002.00 USD 14,544,760.71 44.753  ...
-

Harvest Introduces Six Enhanced High‑Income Shares ETFs, Setting Sector Leadership on the TSX

OAKVILLE, Ontario--(BUSINESS WIRE)--Harvest Portfolios Group Inc. (“Harvest”) is pleased to announce the completion of the initial offering of Class A Units of the Harvest Enhanced High Income Shares ETFs TM, outlined in the table below, pursuant to a prospectus dated January 8, 2026, filed with the securities regulatory authorities in all of the Canadian provinces and territories. The Class A Units of the Harvest Enhanced High Income Shares ETFs TM will commence trading on the Toronto Stock Ex...
-

Tortoise Capital to Launch Energy & Infrastructure Interval Fund, Expanding Access to Public and Private Markets

OVERLAND PARK, Kan.--(BUSINESS WIRE)--Tortoise Capital announces Tortoise Energy & Infrastructure Interval Fund, expected to launch in the second half of 2026, pending regulatory approval....
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust FactorFX UCITS ETF 14.01.2026 FXGB LN IE00BD5HBR05 37,992.00 GBP 743,468.73 26.333  ...
-

InterAx and Alveus Announce Strategic Research and Licensing Agreement to Develop Differentiated Therapeutic Candidate for Metabolic Disease

ZURICH & PHILADELPHIA & COPENHAGEN, Denmark--(BUSINESS WIRE)--InterAx Biotech Ltd (“InterAx”) and Alveus Therapeutics Inc. (“Alveus”) today announced a strategic research collaboration and licensing agreement to develop a differentiated small molecule candidate for metabolic disease to deliver durable weight loss with superior tolerability. This partnership forms a joint research effort on a target and modality of established but untapped therapeutic interest by combining InterAx’s Deep Signal™...